"Standard & Poor's (NYSE:MHP) Ratings Services said the current global market for prescription drugs to treat obesity-related illnesses, such as diabetes, cardiovascular disorders, hypertension, and high cholesterol is at about 70 bln usd but will double by 2020, assuming this market grows at a compound average of just 5 pct per year...Thanks for doing what you can for Big Pharma.
A World Health Organization(WHO) projection says that the number of adults overweight worldwide will rise to 2.3 bln by 2015 from 1.6 bln now, and that obesity levels will rise to 700 mln from 400 mln."
Fitness Watch is your site for making sense of fitness advice.
"Truth" has a shelf life.
The shelf life of "truth" is very short in the domains of fitness, health and well-being.
The reason is that so much of what we are told is "true" is really baseless.
At Fitness Watch we separate fitness information from fitness noise.
Monday, March 03, 2008
Obesity drugs will keep global pharmaceutical firms' bottomlines bulging - S&P
Kudos, fatsos.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.